680 related articles for article (PubMed ID: 18598942)
1. Menin critically links MLL proteins with LEDGF on cancer-associated target genes.
Yokoyama A; Cleary ML
Cancer Cell; 2008 Jul; 14(1):36-46. PubMed ID: 18598942
[TBL] [Abstract][Full Text] [Related]
2. A MENage à Trois in leukemia.
Roudaia L; Speck NA
Cancer Cell; 2008 Jul; 14(1):3-5. PubMed ID: 18598937
[TBL] [Abstract][Full Text] [Related]
3. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
4. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
5. Unlike Its Paralog LEDGF/p75, HRP-2 Is Dispensable for MLL-R Leukemogenesis but Important for Leukemic Cell Survival.
Van Belle S; El Ashkar S; Čermáková K; Matthijssens F; Goossens S; Canella A; Hodges CH; Christ F; De Rijck J; Van Vlierberghe P; Veverka V; Debyser Z
Cells; 2021 Jan; 10(1):. PubMed ID: 33477970
[TBL] [Abstract][Full Text] [Related]
6. The same site on the integrase-binding domain of lens epithelium-derived growth factor is a therapeutic target for MLL leukemia and HIV.
Murai MJ; Pollock J; He S; Miao H; Purohit T; Yokom A; Hess JL; Muntean AG; Grembecka J; Cierpicki T
Blood; 2014 Dec; 124(25):3730-7. PubMed ID: 25305204
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.
Chen Y; Jones KL; Anastassiadis K; Kranz A; Stewart AF; Grembecka J; Meyerson M; Ernst P
Exp Hematol; 2019 Jan; 69():37-42. PubMed ID: 30315824
[TBL] [Abstract][Full Text] [Related]
8. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.
Yokoyama A; Wang Z; Wysocka J; Sanyal M; Aufiero DJ; Kitabayashi I; Herr W; Cleary ML
Mol Cell Biol; 2004 Jul; 24(13):5639-49. PubMed ID: 15199122
[TBL] [Abstract][Full Text] [Related]
9. The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.
Huang J; Gurung B; Wan B; Matkar S; Veniaminova NA; Wan K; Merchant JL; Hua X; Lei M
Nature; 2012 Feb; 482(7386):542-6. PubMed ID: 22327296
[TBL] [Abstract][Full Text] [Related]
10. Validation and structural characterization of the LEDGF/p75-MLL interface as a new target for the treatment of MLL-dependent leukemia.
Cermáková K; Tesina P; Demeulemeester J; El Ashkar S; Méreau H; Schwaller J; Rezáčová P; Veverka V; De Rijck J
Cancer Res; 2014 Sep; 74(18):5139-51. PubMed ID: 25082813
[TBL] [Abstract][Full Text] [Related]
11. Menin as a hub controlling mixed lineage leukemia.
Thiel AT; Huang J; Lei M; Hua X
Bioessays; 2012 Sep; 34(9):771-80. PubMed ID: 22829075
[TBL] [Abstract][Full Text] [Related]
12. MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development.
Kim HS; Oh SH; Kim JH; Kim JY; Kim DH; Lee SJ; Choi SU; Park KM; Ryoo ZY; Park TS; Lee S
Haematologica; 2017 Nov; 102(11):e434-e437. PubMed ID: 28798069
[No Abstract] [Full Text] [Related]
13. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
[TBL] [Abstract][Full Text] [Related]
14. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
15. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.
Jin S; Zhao H; Yi Y; Nakata Y; Kalota A; Gewirtz AM
J Clin Invest; 2010 Feb; 120(2):593-606. PubMed ID: 20093773
[TBL] [Abstract][Full Text] [Related]
16. LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis.
El Ashkar S; Schwaller J; Pieters T; Goossens S; Demeulemeester J; Christ F; Van Belle S; Juge S; Boeckx N; Engelman A; Van Vlierberghe P; Debyser Z; De Rijck J
Blood; 2018 Jan; 131(1):95-107. PubMed ID: 29084774
[TBL] [Abstract][Full Text] [Related]
17. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.
Grembecka J; He S; Shi A; Purohit T; Muntean AG; Sorenson RJ; Showalter HD; Murai MJ; Belcher AM; Hartley T; Hess JL; Cierpicki T
Nat Chem Biol; 2012 Jan; 8(3):277-84. PubMed ID: 22286128
[TBL] [Abstract][Full Text] [Related]
18. A reconfigured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit.
Blobel GA; Kadauke S; Wang E; Lau AW; Zuber J; Chou MM; Vakoc CR
Mol Cell; 2009 Dec; 36(6):970-83. PubMed ID: 20064463
[TBL] [Abstract][Full Text] [Related]
19. Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation.
Sharma S; Čermáková K; De Rijck J; Demeulemeester J; Fábry M; El Ashkar S; Van Belle S; Lepšík M; Tesina P; Duchoslav V; Novák P; Hubálek M; Srb P; Christ F; Řezáčová P; Hodges HC; Debyser Z; Veverka V
Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7053-E7062. PubMed ID: 29997176
[TBL] [Abstract][Full Text] [Related]
20. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.
So CW; Lin M; Ayton PM; Chen EH; Cleary ML
Cancer Cell; 2003 Aug; 4(2):99-110. PubMed ID: 12957285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
